Nattokinase
Best-in-class: Nattokinase
An enzyme from fermented soy (natto) that supports healthy blood flow by promoting fibrin breakdown (a natural clot-management effect).
Nattokinase quick facts
| Suggested dose | 2,000 FU daily. |
| How often | Daily |
| Who it's for | Circulation, blood-pressure and clot-management support. |
The best-evidenced of the fibrinolytic enzymes, with one trial showing reduced carotid plaque progression — a structural endpoint, which is rare in this category. The anticoagulant interaction is real rather than theoretical: combined with warfarin, a DOAC, aspirin or fish oil it meaningfully raises bleeding risk, and it needs stopping before surgery. Natto itself is also extremely high in vitamin K2, though most extracts remove it.
How Nattokinase actually works
A serine protease from fermented soy that degrades fibrin directly and also raises endogenous fibrinolytic activity by reducing plasminogen activator inhibitor-1. Unlike most oral enzymes it appears to survive digestion in meaningful quantity, and trials show reduced fibrinogen and improved blood rheology.
Where to get Nattokinase
Find Nattokinase on iHerb →The evidence for Nattokinase
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show reduced blood pressure and fibrinogen, and support for healthy circulation/clot management.
- Fibrinolytic (clot-dissolving) activity is well-characterized.
📊 Correlative data
- Elevated fibrinogen tracks with cardiovascular and clotting risk.
🧪 Theoretical / extrapolated benefits
- Broad cardiovascular-protection claims follow from the fibrinolytic mechanism.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Nattokinase actually does
Hemostasis is not a level, it is a controller with enormous reserve, and that is why a proteolytic nudge from a capsule is absorbed. Fibrin formation and dissolution are held in balance by opposing enzymatic cascades: thrombin generation opposed by antithrombin, protein C and tissue factor pathway inhibitor; plasminogen activation by tissue plasminogen activator opposed by plasminogen activator inhibitor-1 and alpha-2-antiplasmin Singh 2023. Every arm has a brake. Push one and the others adjust.
Nattokinase itself is a well-characterized enzyme. It is a 27.7 kilodalton subtilisin-family serine protease produced by Bacillus subtilis natto, and it cleaves fibrin directly rather than by activating plasminogen, which distinguishes it from the clinical thrombolytics. Its place among the microbial fibrinolytic enzymes is well described Hazare 2024.
The problem the label never states is that a 27.7 kilodalton protein has to cross the one organ built to destroy proteins. Gastric acid denatures it, pepsin and pancreatic proteases cleave it, and intact absorption of a protein that size across the intestinal epithelium is a small and poorly quantified fraction at best. That is the step every claim on this page rests on, and it is why the enteric coating question below is not a detail.
There is nonetheless an acute human pharmacodynamic signal, which is the interesting part. A single oral dose accelerated skin temperature recovery after cold water immersion in a double-blind placebo-controlled crossover study Nara 2023. A microvascular read-out that responds to one dose implies something systemically active reached the circulation, whether that is intact enzyme, an active fragment, or a peptide acting on a different target.
And even granting delivery, the controller sets the ceiling. A small fibrinolytic push against a system with antiplasmin and plasminogen activator inhibitor-1 in reserve produces a correspondingly small net change, which is exactly the size of effect the human trials report Li 2023.
Cell, rodent, human — and where it stops
The clinical evidence is better than a skeptic expects and smaller than the marketing implies.
What has been randomized and pooled. A randomized controlled atherothrombotic prevention study exists Hodis 2021, cardiovascular risk factors have been meta-analyzed across randomized controlled trials Li 2023, and real-world safety data have been reported in patients with vascular disease Gallelli 2021. For a fermented food enzyme that is a substantial file.
The specific obstacle is that the endpoints are surrogates that the body re-normalizes. Fibrinogen, D-dimer and blood pressure are all regulated, and a pooled analysis of risk factors Li 2023 is not a trial of events. The one study designed around atherosclerosis progression Hodis 2021 is the closest thing to an outcome trial this literature has, and it is single.
The pharmacokinetic step is missing entirely. No published human study reports plasma nattokinase activity after an oral dose. The cold-immersion result Nara 2023 is the strongest indirect evidence that something arrives, and it is indirect.
And the unit is not a mass. Doses are expressed in fibrinolytic units, an activity measure from a fibrin plate assay, which means two products at 2,000 FU may contain different masses of protein and different amounts of everything else in the fermentate Hazare 2024. Pooling trials by fibrinolytic units assumes an assay equivalence nobody has demonstrated.
Nattokinase — which form, and does it matter
The dose unit is an activity assay and that is the most important line on the panel. 2,000 fibrinolytic units is the common daily dose and it describes what the material DOES in a plate assay, not how much of it there is. A product declaring milligrams of natto extract without fibrinolytic units has told you nothing about potency Hazare 2024.
Enteric coating is the difference between a plausible product and an implausible one. A subtilisin-family protease exposed to gastric acid and pepsin is substantially destroyed. If the mechanism requires intact enzyme in the intestine, then acid protection is the whole delivery strategy, and an uncoated capsule is a different product Singh 2023.
Nattokinase is not natto, and the difference matters for one specific reason. Whole natto is rich in vitamin K2 as menaquinone-7, which is procoagulant in the sense that it supports gamma-carboxylation of clotting factors and directly antagonizes warfarin. Purified nattokinase preparations are generally vitamin-K-depleted, and a product that does not say so should be assumed to contain some.
Which makes vitamin K content the single specification a warfarin patient must have, and almost no panel declares it Gallelli 2021. A supplement that both thins blood by one mechanism and thickens it by another, without declaring the second, is the worst possible object to hand to somebody on an anticoagulant.
What would have to be true, and how you would know it was not
1. The coagulation prediction, at 8 weeks. Fibrinogen and D-dimer at baseline and 8 weeks on 2,000 fibrinolytic units. Predict a small fall in fibrinogen and little movement in D-dimer, because the pooled data describe modest changes in risk factors Li 2023. A large D-dimer change would suggest active fibrin turnover somewhere and is a reason to see a doctor rather than to feel encouraged.
2. The blood pressure prediction, at 8 weeks. Home systolic pressure averaged over 7 mornings. Predict a small fall, consistent with the pooled cardiovascular risk factor analysis Li 2023.
3. The acute prediction, which is the mechanism test a person can almost run. The published cold-water-immersion design measured skin temperature recovery after a single dose Nara 2023. Predict faster rewarming after one dose than after placebo. If a single dose does nothing acutely, the delivery question is unresolved and every chronic claim inherits that.
4. The bleeding prediction, which is the safety one. Watch for gum bleeding, easy bruising and prolonged bleeding from small cuts, and check a full blood count and, if anticoagulated, an INR at 4 weeks. Predict no change in most people and a detectable shift in anyone already on an antiplatelet or anticoagulant Gallelli 2021.
5. The study that would settle the whole page. Measure plasma fibrinolytic activity at 0, 2, 4 and 8 hours after an enteric-coated and a non-coated 2,000 FU dose. Prediction: measurable activity from the coated form and little from the uncoated Singh 2023. If neither shows systemic activity, the acute microvascular result Nara 2023 is working through something other than intact enzyme and this page has the mechanism wrong.
What nobody has tested yet
Nobody has published human pharmacokinetics. There is no plasma activity curve after an oral dose of nattokinase, which means the absorption step underneath every claim is undemonstrated Hazare 2024.
Nobody has compared coated and uncoated head to head. The gastric destruction argument is strong Singh 2023 and no trial has tested whether the coating changes the clinical result.
Nobody has standardized the fibrinolytic unit across manufacturers. The unit is an assay output Hazare 2024, and cross-product equivalence has not been established, so the pooled analyses Li 2023 are pooling doses that may not be comparable.
And nobody has run an event-driven outcome trial. The atherothrombotic prevention study is the closest Hodis 2021 and the endpoints across this literature remain surrogates. For an agent whose proposed benefit is preventing thrombosis, that gap is the whole question.
Nattokinase — its own safety story, not its category's
The risk that belongs to this product rather than to its category is bleeding, and it is pharmacodynamic, which is what makes it hard to see coming. It does not change the blood level of any drug, so there is no interaction to detect on a laboratory panel until the bleeding itself appears. Alongside warfarin, apixaban, rivaroxaban, clopidogrel or aspirin at any dose, the effects add Gallelli 2021, and the signs are bruising, nosebleeds, bleeding gums or a rising INR.
Surgery and dental work need a stop date. A fibrinolytic supplement should be stopped well before a planned procedure and named on the pre-operative medication list, because a surgeon who does not know it is there cannot account for it Singh 2023.
The vitamin K question runs the other way and is the one people get wrong. Whole natto is exceptionally rich in menaquinone-7, which antagonizes warfarin. Purified nattokinase is usually vitamin-K-depleted and the panel often does not say. A warfarin patient therefore faces two opposite risks from two versions of the same product name, and the only safe course is to have the prescriber see the label.
Recent stroke, an active bleed or a known aneurysm is a stop. This is not a nutrient with a theoretical mechanism; it is a protease sold for its ability to break down fibrin Hazare 2024, and the population most attracted to it overlaps with the population least able to afford a bleed.
And the soy note is real. The product is a fermented soy derivative, so soy allergy is a contraindication, and gastrointestinal upset is the ordinary complaint Gallelli 2021. Nothing here is medical advice, and none of these statements has been evaluated by the Food and Drug Administration.
Sources read for this page
- Singh R. Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role. Life (Basel) 2023 · PMID 38004336
- Hodis HN. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clin Hemorheol Microcirc 2021 · PMID 33843667
- Li X. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Rev Cardiovasc Med 2023 · PMID 39076715
- Nara N. A single dose of oral nattokinase accelerates skin temperature recovery after cold water immersion: A double-blind, placebo-controlled crossover study. Heliyon 2023 · PMID 37483751
- Gallelli G. Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases. Nutrients 2021 · PMID 34199189
- Hazare C, et al. Diverse origins of fibrinolytic enzymes: A comprehensive review.. Heliyon 2024 · PMID 38434287
How you would know if it worked
Fibrinogen is the marker that recommends this product on its own page here, and it is also the endpoint natto's own randomized trials report, so the prediction is specific: fibrinogen down at 2,000 FU a day, measured against a draw taken before the first capsule rather than a single value afterwards. D-dimer sits beside it because a fibrinolytic mechanism predicts fibrin breakdown products, and because a D-dimer that climbs on an enzyme sold for clot management is information worth having early. The blood pressure half of the claim is a cuff. And the activity that would move these numbers is the same activity that makes this a poor idea alongside an anticoagulant or in the fortnight before surgery.
- Fibrinogen Activity — Nattokinase is used by some, though evidence is limited Retest: Every 6–12 months if elevated.
- D-Dimer Retest: Only as directed clinically.
The cheapest panel carrying Fibrinogen Activity and at least one other of these is Clotting & Advanced Cardiac Risk, at $504 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Nattokinase — safety & side effects
- Generally well tolerated. GI upset is the usual report.
- It is fibrinolytic — it breaks down fibrin. Additive bleeding risk with anticoagulants and antiplatelets — warfarin, apixaban, rivaroxaban, clopidogrel, and aspirin at any dose. The interaction is pharmacodynamic rather than metabolic, so it does not show up as a changed drug level; it shows up as bruising, nosebleeds or a raised INR. Bleeding events including intracranial hemorrhage have been reported alongside anticoagulants.
- Avoid with active bleeding, a bleeding disorder, or recent stroke. Natto is also very high in vitamin K2, though most extracts remove it — check, if you take warfarin.
The same on every page it applies to. Read it here; it is not repeated research.
- Stop at least two weeks before any surgery or dental extraction. Surgeons ask about prescription blood thinners and rarely about supplements, so this one is on you to volunteer.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Nattokinase in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Nattokinase
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Fibrinogen Activity | Directly fibrinolytic — this is the marker it acts on |
| Complete Blood Count (CBC) with Differential | Platelet count before anything with antiplatelet activity |
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | Why most people are taking it |
| Comprehensive Metabolic Panel (CMP) | Baseline organ function |
The Real Cardiovascular Risk panel covers these in one order — 9 markers, $187.60 with the discount applied.
Check results you already have → · All 103 markers A–Z
Nattokinase — frequently asked questions
What is Nattokinase?
An enzyme from fermented soy (natto) that supports healthy blood flow by promoting fibrin breakdown (a natural clot-management effect).
What is the suggested dose of Nattokinase?
2,000 FU daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Nattokinase dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Nattokinase?
Coach Cam sources Nattokinase from vetted, top-rated brands on iHerb — use the buy link on this page.
Nattokinase inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Nattokinase is used for
Nattokinase appears under 1 goal in the goal router.
Related Cardiovascular supplements
Where this goes next
Nattokinase is the residual risk arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.